These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1950265)

  • 1. [Escherichia coli reactions to the action of the cationic proteins of blood leukocytes].
    Zhdan-Pushkina SM; Rybakova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):5-8. PubMed ID: 1950265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of the cationic proteins of human blood cells on the growth of Escherichia coli].
    Rybakova LP; Zhdan-Pushkina SM
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):3-7. PubMed ID: 2201153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The in-vitro effect of the leukocytic cationic protein preparation Intercide on Escherichia coli].
    Bukharin OV; Gritsenko VA
    Antibiot Khimioter; 2000; 45(1):16-20. PubMed ID: 10690423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance of Escherichia coli to "Intercid", a leukocyte cation protein].
    Gritsenko VA; Shukhman MG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4 Suppl):71-6. PubMed ID: 12712518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and assay of bactericidal/permeability-increasing protein.
    Weiss J
    Methods Enzymol; 1994; 236():173-96. PubMed ID: 7968609
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro activity of an antibacterial substance from rabbit polymorphonuclear leukocytes.
    Agarwal MK; Prixova J; Chedid L
    J Infect Dis; 1972 Aug; 126(2):131-5. PubMed ID: 4626542
    [No Abstract]   [Full Text] [Related]  

  • 7. Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.
    Levy O; Ooi CE; Weiss J; Lehrer RI; Elsbach P
    J Clin Invest; 1994 Aug; 94(2):672-82. PubMed ID: 8040321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of antibacterial activities of the bactericidal/permeability-increasing protein in natural biological fluids.
    Weiss J
    Methods Mol Biol; 1997; 78():217-31. PubMed ID: 9276307
    [No Abstract]   [Full Text] [Related]  

  • 9. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
    Vaara M; Viljanen P; Vaara T; Mäkelä PH
    J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA; Weiss J; Elsbach P
    J Clin Invest; 1990 Mar; 85(3):853-60. PubMed ID: 2179269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.
    Weiss J; Elsbach P; Olsson I; Odeberg H
    J Biol Chem; 1978 Apr; 253(8):2664-72. PubMed ID: 344320
    [No Abstract]   [Full Text] [Related]  

  • 13. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA; Kalatzis ES; Weiss J; Elsbach P
    J Immunol; 1989 Apr; 142(8):2807-12. PubMed ID: 2539411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive assays for endogenous antimicrobial polypeptides.
    Lehrer RI; Rosenman M; Harwig SS; Jackson R; Eisenhauer P
    J Immunol Methods; 1991 Mar; 137(2):167-73. PubMed ID: 1901580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli.
    Weiss J; Franson RC; Beckerdite S; Schmeidler K; Elsbach P
    J Clin Invest; 1975 Jan; 55(1):33-42. PubMed ID: 1088909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of cationic proteins from human granulocytes.
    Odeberg H; Olsson I
    J Clin Invest; 1975 Nov; 56(5):1118-24. PubMed ID: 241758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.
    Lehrer RI; Barton A; Daher KA; Harwig SS; Ganz T; Selsted ME
    J Clin Invest; 1989 Aug; 84(2):553-61. PubMed ID: 2668334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial host defense: in vitro interaction of bacteria, serum factors, and leukocytes from precolostral dairy calves and their dams.
    Renshaw HW; Eckblad WP; Thacker DL; Frank FW
    Am J Vet Res; 1976 Nov; 37(11):1267-74. PubMed ID: 791028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OmpR-dependent and OmpR-independent responses of Escherichia coli to sublethal attack by the neutrophil bactericidal/permeability increasing protein.
    Prohinar P; Forst SA; Reed D; Mandic-Mulec I; Weiss J
    Mol Microbiol; 2002 Mar; 43(6):1493-504. PubMed ID: 11952900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.